US equities
|
SPCX
$168.84
▲+6.21%
NVDA
$237.77
▲+1.63%
MU
$1,065.25
▼-0.90%
TSLA
$380.72
▲+2.73%
MSFT
$525.34
▲+1.51%
SNDK
$1,715.14
▼-0.28%
INTC
$116.95
▼-1.99%
META
$745.35
▲+2.37%
SPCX
$168.84
▲+6.21%
NVDA
$237.77
▲+1.63%
MU
$1,065.25
▼-0.90%
TSLA
$380.72
▲+2.73%
MSFT
$525.34
▲+1.51%
SNDK
$1,715.14
▼-0.28%
INTC
$116.95
▼-1.99%
META
$745.35
▲+2.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Kezar Life Sciences, Inc. - Common Stock
(NQ:
KZR
)
7.290
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kezar Life Sciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 02, 2021
Gainers Tilray (NASDAQ:TLRY) shares incre...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
↗
June 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...
Via
Benzinga
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
June 02, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors
June 01, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
↗
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference
May 27, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021
May 26, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
May 12, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Recognized as 2021 Bay Area Best Places to Work
May 10, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
April 10, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
